Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P1SA
|
|||
| Former ID |
DIB016947
|
|||
| Drug Name |
Autologous endothelial progenitor cell therapy
|
|||
| Synonyms |
Autologous endothelial progenitor cell therapy (ischemia); Autologous endothelial progenitor cell therapy (ischemia), IBRI; Autologous stem cell therapy (critical limb ischemia), IBRI; Autologous CD34+ cells (peripheral vascular disease), IBRI
Click to Show/Hide
|
|||
| Indication | Ischemic heart disease [ICD-11: BA40-BA6Z; ICD-10: I20-I25; ICD-9: 410-414] | Phase 2/3 | [1] | |
| Company |
Kobe Institute of Biomedical Research and Innovation
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases. Curr Opin Mol Ther. 2008 Dec;10(6):611-21. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.